Actively Recruiting

Phase Not Applicable
Age: 20Years - 90Years
All Genders
NCT06497296

The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray

Led by National Cheng-Kung University Hospital · Updated on 2024-07-11

160

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Esophagogastroduodenoscopy (EGD) is the main examination in the upper gastrointestinal field. Aspiration pneumonia may happen if choking occurs during the EGD insertion, and the exam quality and efficacy may be affected if gag reflex occurs. The endoscopist may terminate the exam to avoid complications if the patient could not obey the orders. To reach the high quality of EGD examination and to avoid possible complications, the patient's comfort and compliance during the EGD examination are important. Sedation using propofol can improve the patient's comfort and compliance. However, in patients unsuitable for systemic anesthesia, local lidocaine spray at pharynx is performed instead. Until now, there is no standardization of the waiting time between lidocaine spray and the initiation of EGD. This study aimed to investigate the optimal timing of the initiation of esophagogastroduodenoscopy after lidocaine spray.

CONDITIONS

Official Title

The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray

Who Can Participate

Age: 20Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 20 years or older
  • Scheduled for EGD from outpatient department
  • Diagnosed with or being evaluated for dyspepsia, peptic ulcer disease, GERD, subepithelial lesion, or diarrhea
Not Eligible

You will not qualify if you...

  • Active gastrointestinal bleeding
  • Scheduled for endoscopic submucosal dissection due to longer procedure time
  • Patients from emergency department or hospital wards

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hsueh-Chien Chiang

Tainan, Other (Non U.s.), Taiwan, 704

Actively Recruiting

Loading map...

Research Team

H

Hsueh-Chien Chiang, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here